Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

Product › Details

cancer immunotherapy (immuno-oncology, I-O)

	Next higher product group	cancer drug
	Status	2012-10-06

Record changed: 2023-01-29

Picture EasyFairs Connect in Pharma 2023 Geneva Networking 650x200px

More documents for cancer immunotherapy (immuno-oncology, I-O)

[1] IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY....
[2] Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel....
[3] Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim....
[4] Targovax ASA. (2/28/22). "Press Release: Targovax ASA Strengthens Management with Lubor Gaal as Chief Financial Officer". Oslo....
[5] Strike Pharma AB. (2/22/22). "Press Release: Strike Pharma Completes 45 MSEK Financing Round". Uppsala....
[6] Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen....
[7] IO Biotech, Inc.. (11/9/21). "Press Release: IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares". Wilmington, DE....
[8] Asgard Therapeutics AB. (11/9/21). "Press Release: Asgard Therapeutics Raises EUR 6M in Seed Financing to Exploit Direct in vivo Reprogramming". Lund....
[9] IO Biotech, Inc.. (11/4/21). "Press Release: IO Biotech, Inc. Announces Pricing of Initial Public Offering". Wilmington, DE....
[10] Zelluna Immunotherapy AS. (8/19/21). "Press Release: Exclusive License Agreement with the U.S. National Cancer Institute to Develop and Commercialize KK-LC-1 Targeting Allogeneic »Off-the-Shelf« TCR Based Natural Killer (TCR-NK) Cell Therapies". Oslo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)